Former President Jimmy Carter believes in miracles, and maybe he got one in the astonishingly rapid disappearance of four cancerous lesions on his brain. But don’t discount the role of science, particularly the new immune-system therapies that show promise in helping the human body destroy cancer cells.

Mr. Carter, who is 91, revealed in August that he had melanoma. He said doctors found four lesions on his brain, and he would undergo radiation and have a portion of his liver removed. When the cancer was discovered, he told supporters, “I just thought I had a few weeks left.”

Last weekend, however, he told his Sunday school class at a Baptist church in Plains, Ga., that after just three months of treatment, the lesions have vanished and doctors have found no new cancer. Given Mr. Carter’s age and family history — his brother, sisters and parents all died of cancer — this is amazing, and his improvement offers hope for the nearly 75,000 Americans who will be diagnosed with melanoma in the coming year.

The former president’s cancer was treated with a combination of radiation, surgery (about a tenth of his liver was removed) and immunotherapy, a new course of treatment aimed at improving the body’s natural immune system rather than poisoning the cancer cells. He was treated with Keytruda, a drug that was just approved by the Food and Drug Administration little more than a year ago. That and another new drug called Opdivo have shown promise in the treatment of melanoma, the most deadly form of skin cancer.

Advertise with us

While 10,000 Americans will die from melanoma this year, survival rates are rising. The National Cancer Institute says the average survival rate increased from 49 percent in the 1950s to 91 percent for early-stage patients today. The new immunotherapies will help even more.

Mr. Carter did not say that his cancer has been cured, only that the lesions had disappeared, and doctors will closely monitor him in the coming months for signs of recurrence. For now, though, the news is good, and you don’t have to approve of his presidency to wish him well.

Meet the Editorial Board.